iNova Pharmaceuticals’s $13.5 million Acquisition of Probiotec’s Gold Cross, David Craig and Skin Basics brands

Arnold Bloch Leibler advised ASX-listed Probiotec Limited on the deal Probiotec executed an agreement to sell pharmaceutical brands Gold Cross, David Craig and Skin Basics, including…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here